Forest Laboratories, Inc. Announces Positive Results Of Memantine Study Of Once-Daily Formulation
Forest Laboratories, Inc. (NYSE: FRX) announced preliminary results of a Phase III study of memantine HCl (currently marketed as Namenda(R), a twice-daily immediate- release formulation) in a novel once-daily formulation.
More: continued here
Filed under: Alzheimer's / Dementia News XML/RSS Feed on February 7th, 2008